ArentFox Schiff Advises GBS Inc. on Acquisition of Intelligent Fingerprinting

ArentFox Schiff advised GBS Inc. (Nasdaq: GBS) on its acquisition of Intelligent Fingerprinting Limited, including its proprietary drugs of abuse screening technology.

GBS is a life sciences company developing non-invasive, real-time diagnostic testing for patients and their primary health practitioners at point of care. The acquisition expands the GBS platform of rapid, non-invasive diagnostic testing technologies.

The transaction was completed on October 4, 2022.

Smart In Your World
Your goals define our mission. Whether an immediate need or a long-term objective, ArentFox Schiff helps you reach your full potential. As industry insiders, we partner with you to develop practical business strategies and sophisticated legal solutions to achieve today’s targets and anticipate tomorrow’s problems. We get you across the finish line.


Continue Reading